IDiyas

For the Inventor, By the Inventor

Brantford, Canada

Yajun Zhao

USPTO Granted Patents = 19 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:

goldMedal12 out of 50 
 
Apotex Pharmachem Inc.
 patents
silverMedal7 out of 65 
 
Apotex Inc.
 patents

Years Active: 2006-2023

Loading Chart...
19 patents (USPTO):Explore Patents
1. 11661396 - Crystalline forms of zuclomiphene citrate (2023-05-30),
2. 11440871 - Zuclomiphene salts and crystalline forms thereof (2022-09-13),
3. 11220500 - Crystalline form of Valbenazine dibesylate (2022-01-11),
4. 10875846 - Processes for the preparation of Tezacaftor and intermediates thereof (2020-12-29),
5. 9944616 - Processes for the preparation of Tasimelteon and intermediates thereof (2018-04-17),
6. 9533949 - Processes for the preparation of 3-alkyl indoles (2017-01-03),
7. 9382272 - Methods of making lubiprostone and intermediates thereof (2016-07-05),
8. 9382233 - Forms of vilazodone and processes for the preparation thereof (2016-07-05),
9. 9376419 - Solid forms of nilotinib hydrochloride (2016-06-28),
10. 9359374 - Polymorphic forms of rifaximin (2016-06-07),
11. 8835638 - 1,3-Oxathiolane derivatives, process for the preparation of 1,3-Oxathiolane derivatives and intermediates thereof (2014-09-16),
12. 8188300 - Atorvastatin calcium propylene glycol solvates (2012-05-29),
13. 7834195 - Atorvastatin calcium propylene glycol solvates (2010-11-16),
14. 7812179 - Process for the preparation of atorvastatin and intermediates (2010-10-12),
15. 7615647 - Process for producing atorvastatin hemicalcium (2009-11-10),

Title: Yajun Zhao: Pioneering Innovator in Pharmaceutical Technology

Introduction:

Yajun Zhao, a visionary inventor based in Brantford, Canada, has left an indelible mark on the world of pharmaceutical technology with his groundbreaking innovations and relentless dedication to pushing the boundaries of what is possible.

Latest Patents:

Yajun Zhao's latest patents include the discovery of novel crystalline forms of zuclomiphene citrate, such as Forms APO-I, APO-II, APO-III, and APO-IV, which have significant implications in the treatment of disorders like osteoporosis, bone fractures, and hot flashes. Additionally, his invention of zuclomiphene salts and crystalline forms thereof has opened new avenues in pharmaceutical research and development.

Career Highlights:

With an impressive portfolio of 19 patents to his name, Yajun Zhao has cemented his legacy as a pioneering inventor in the field of pharmaceuticals. Having worked at Apotex Pharmachem Inc. and Apotex Inc., Zhao has honed his expertise in developing innovative pharmaceutical solutions that are making a tangible difference in healthcare.

Collaborations:

Throughout his career, Yajun Zhao has collaborated with esteemed colleagues such as Daqing Che and Bhaskar Reddy Guntoori, pooling their knowledge and expertise to drive forward groundbreaking research and development initiatives in the pharmaceutical industry. These collaborations have led to the successful realization of cutting-edge inventions that are transforming the way we approach healthcare.

Conclusion:

Yajun Zhao's passion for innovation, coupled with his unwavering dedication to shaping the future of technology, underscores his status as a visionary inventor. His pioneering work in pharmaceutical technology has not only revolutionized the field but also holds immense promise for improving the lives of countless individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…